FDA recall,
Teva Dasatinib Tablets
Some bottles of Teva Dasatinib Tablets labeled 100 mg contain 50 mg tablets, a product mix-up.
What to do
Check yoursIf a code on your package is listed below:
- Don't stop taking it without talking to your pharmacist or doctor; ask them whether your lot is recalled.
Typical advice for a recalled medicine; the FDA notice gives no product-specific instructions.
What happened
Teva Pharmaceuticals USA, Inc., of Parsippany, New Jersey, is recalling 1,992 bottles of Teva Dasatinib Tablets, 100 mg, with 30 tablets per bottle. The company started the recall on its own. The recall was prompted by a product mix-up: 50mg Dasatinib tablets were found in two bottles of Dasatinib 100mg tablets.
The affected bottles were distributed nationwide in the USA. The company told customers by telephone. The company began the recall on November 3, 2026, and the FDA added it to its Enforcement Report on November 18, 2026.
Is yours affected?
Match the lot code and NDC listed under your product.
An NDC (National Drug Code) is usually printed on the drug's label.
Dasatinib Tablets
- Strength
- 100 mg
- NDC
- 0480-5104-56
- Lot code
- 6267124
Recall details
- Posted by FDA
- Recall began
- Status
- Open
- Weekly archive
- Listed the week of Nov 16, 2026
- Sold in
Distributed nationwide.
- Recalled by
- Teva Pharmaceuticals USA, IncParsippany, New Jersey
- Hazard
- Labeling error
- Risk
Not yet rated by FDA
- FDA event number
- 100273
- Quantity recalled
- 1,992 bottles
- Recall type
- Started by the company
- How the company first told customers
- Phone
All recalls from Teva Pharmaceuticals USA, Inc
Timeline
FDA's Enforcement Report is its public list of recalls; FDA posts a recall by adding it there.
Teva Pharmaceuticals USA began the recall
FDA posted the recall to its Enforcement Report
Added to Recall Canary


